Coronary disease & ACSCohort study

Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA

Eur Heart JPublished

  • Retrospective cohort study
  • Medicare beneficiaries
  • multivariable Cox regression
  • falsification endpoints

Authors' conclusion

Among Medicare beneficiaries undergoing PCI, use of IVI has increased over the previous decade but remains relatively infrequent. IVI-guided PCI was associated with lower risk-adjusted mortality, acute MI, repeat PCI, and MACE.

Study context

Population
Medicare beneficiaries undergoing percutaneous coronary intervention (PCI), inpatient and outpatient, USA, 2013–2019
Participants
1,189,470 beneficiaries
Exposure
Intravascular imaging (IVI)-guided PCI vs PCI with angiography guidance alone
Outcome
Mortality and MACE (death, myocardial infarction (MI), repeat PCI or CABG)
Follow-up
1 year

Main finding

As reported in the abstract

IVI vs AngiographyAdjusted hazard ratio (95% CI)
mortality
0.96(0.94–0.98)
MACE
0.85(0.84–0.86)

Observational data: associations, not effects.

Secondary outcomes

OutcomeaHR (95% CI)
MI · 1 year · multivariable Cox regression0.97 (0.95–0.99)
Repeat PCI · 1 year · multivariable Cox regression0.74 (0.73–0.75)

IVI use during PCI (temporal trend and operator variation)

IVI used overall
10.5%
IVI use in 2013
9.5%
IVI use in 2019
15.4%
Median operator IVI use (IQR 0.36%-12.82%)
3.92%

Falsification endpoints (hospitalized pneumonia, hip fracture)

No association with hospitalized pneumonia
aHR 1.02, 95% CI 0.99-1.04
No association with hip fracture
aHR 1.02, 95% CI 0.94-1.10
  • used to assess for potential unmeasured confounding

Original publication

Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA. Eur Heart J. Published 20 July 2023. doi:10.1093/eurheartj/ehad430

Summarised from the published abstract; every number is checked against it